Your browser doesn't support javascript.
loading
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial.
Janssen, Q P; van Dam, J L; Bonsing, B A; Bos, H; Bosscha, K P; Coene, P P L O; van Eijck, C H J; de Hingh, I H J T; Karsten, T M; van der Kolk, M B; Patijn, G A; Liem, M S L; van Santvoort, H C; Loosveld, O J L; de Vos-Geelen, J; Zonderhuis, B M; Homs, M Y V; van Tienhoven, G; Besselink, M G; Wilmink, J W; Groot Koerkamp, B.
  • Janssen QP; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • van Dam JL; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Bos H; Department of Medical Oncology, Tjongerschans Hospital, Heerenveen, The Netherlands.
  • Bosscha KP; Department of Surgery, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
  • Coene PPLO; Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
  • van Eijck CHJ; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
  • Karsten TM; Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • van der Kolk MB; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Patijn GA; Department of Surgery, Isala Hospital, Zwolle, The Netherlands.
  • Liem MSL; Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.
  • van Santvoort HC; Department of Surgery, Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center Utrecht, Utrecht, The Netherlands.
  • Loosveld OJL; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.
  • de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, The Netherlands.
  • Zonderhuis BM; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
  • Homs MYV; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • van Tienhoven G; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Groot Koerkamp B; Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands. b.grootkoerkamp@erasmusmc.nl.
BMC Cancer ; 21(1): 300, 2021 Mar 23.
Article en En | MEDLINE | ID: mdl-33757440
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensayos Clínicos Controlados Aleatorios como Asunto / Quimioradioterapia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensayos Clínicos Controlados Aleatorios como Asunto / Quimioradioterapia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article